Sorry -- we allocate excessive resources with respect to companies, trends, technologies, patents, management, and all things relating to overall valuations. Our feeds come from hundreds of RSS and related intelligence sources from Australia to ... We do not share our research with anyone outside our 3-Country Team. BION was on our buy list from roughly Jan-May. We removed BION for several reasons. The tone and type of PR, management changes, buy backs, patent filings, tech acquisitions of tech you said they said they owned in early 2012, etc. The big negative is cash and revenue. Despite what we read, Hardee is not funding a plant. If you study similar companies in similar circumstances, most do not make it because of a failure to reach production, in this instance revenue. We study trends carefully and it is clear BION has had many changes over the past few months and despite their careful PR, it is easy for experts to see past Friedman's posts and overall co releases.BION should not be a financial company operated by financial investors. We may be wrong, but it would appear the original management team had a better grasp on building a company, image, plant, etc. Sorry Solaking, this is our perspective. We'll continue to watch BION but until such time they can say plant funds are deposited and a plant in Hardee or anywhere is breaking ground we will stay far away from this investment.
Market Data 
Markets 
AI
